Legg Mason Upgrades Cubist Pharmaceuticals

Analyst Christopher Holterhoff believes the anti-infective drug manufacturer's Cubicin label expansion will lead to an uptick in prescriptions in 2006 and 2007

Legg Mason upgrades anti-infective drug manufacturer Cubist Pharmaceuticals (CBST ) to buy from hold.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.